Cambrex Corp Stock in Q4 2017 Driven by Institutional Investors

May 16, 2018 - By Sophie Menendez

Sentiment for Cambrex Corp (NYSE:CBM)

Cambrex Corp (NYSE:CBM) institutional sentiment decreased to 1.15 in 2017 Q4. Its down -0.43, from 1.58 in 2017Q3. The ratio worsened, as 120 hedge funds increased and started new equity positions, while 104 decreased and sold their holdings in Cambrex Corp. The hedge funds in our partner’s database reported: 32.02 million shares, up from 31.63 million shares in 2017Q3. Also, the number of hedge funds holding Cambrex Corp in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 33 Reduced: 71 Increased: 82 New Position: 38.

Cambrex Corporation, a life sciences company, provides various services and products for the development and commercialization of new and generic therapeutics worldwide. The company has market cap of $1.59 billion. The companyÂ’s products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. It has a 15.81 P/E ratio. It serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics.

The stock increased 0.31% or $0.15 during the last trading session, reaching $48.4. About 51,361 shares traded. Cambrex Corporation (NYSE:CBM) has risen 2.87% since May 16, 2017 and is uptrending. It has underperformed by 8.68% the S&P500.

Analysts await Cambrex Corporation (NYSE:CBM) to report earnings on August, 3. They expect $0.66 earnings per share, down 13.16 % or $0.10 from last year’s $0.76 per share. CBM’s profit will be $21.74M for 18.33 P/E if the $0.66 EPS becomes a reality. After $0.72 actual earnings per share reported by Cambrex Corporation for the previous quarter, Wall Street now forecasts -8.33 % negative EPS growth.

Jw Asset Management Llc holds 2.58% of its portfolio in Cambrex Corporation for 50,519 shares. Zpr Investment Management owns 34,730 shares or 2.4% of their US portfolio. Moreover, Ranger Investment Management L.P. has 2.37% invested in the company for 672,427 shares. The New York-based American Capital Management Inc has invested 1.9% in the stock. Neumeier Poma Investment Counsel Llc, a California-based fund reported 341,015 shares.

Since January 1, 0001, it had 0 buys, and 2 sales for $5.33 million activity.

Cambrex Corporation (NYSE:CBM) Ratings Coverage

Ratings analysis reveals 50% of Cambrex Corp’s analysts are positive. Out of 2 Wall Street analysts rating Cambrex Corp, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. CBM was included in 2 notes of analysts from January 16, 2018. The stock of Cambrex Corporation (NYSE:CBM) earned “Buy” rating by William Blair on Tuesday, January 16. The firm has “Neutral” rating given on Wednesday, February 14 by Longbow.

More recent Cambrex Corporation (NYSE:CBM) news were published by: Globenewswire.com which released: “Cambrex Completes Pilot Plant Expansion at its High Point, NC Facility” on May 15, 2018. Also Seekingalpha.com published the news titled: “Cambrex’s (CBM) CEO Steven Klosk on Q1 2018 Results – Earnings Call Transcript” on May 05, 2018. Globenewswire.com‘s news article titled: “Cambrex Reports First Quarter 2018 Financial Results” with publication date: May 03, 2018 was also an interesting one.

Cambrex Corporation (NYSE:CBM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: